Try our beta test site
1 study found for:    NCT01491737
Show Display Options
Rank Status Study
1 Recruiting A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Patients With Hormone Receptor-Positive, Metastatic HER2-positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Aromatase Inhibitor;   Drug: Induction Chemotherapy;   Drug: pertuzumab;   Drug: trastuzumab

Study has passed its completion date and status has not been verified in more than two years.